1
|
Tyson GL and El-Serag HB: Risk factors for
cholangiocarcinoma. Hepatology. 54:173–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kim SA, Lee JM, Lee KB, Kim SH, Yoon SH,
Han JK and Choi BI: Intrahepatic mass-forming cholangiocarcinomas:
Enhancement patterns at multiphasic CT, with special emphasis on
arterial enhancement pattern-Correlation with clinicopathologic
findings. Radiology. 260:148–157. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lim JH: Cholangiocarcinoma: Morphologic
classification according to growth pattern and imaging findings.
AJR Am J Roentgenol. 181:819–827. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sheng RF, Zeng MS, Rao SX, Ji Y and Chen
LL: MRI of small intrahepatic mass-forming cholangiocarcinoma and
atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and
chronic viral hepatitis: A comparative study. Clin Imaging.
38:265–272. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Rimola J, Forner A, Reig M, Vilana R, de
Lope CR, Ayuso C and Bruix J: Cholangiocarcinoma in cirrhosis:
Absence of contrast washout in delayed phases by magnetic resonance
imaging avoids misdiagnosis of hepatocellular carcinoma.
Hepatology. 50:791–798. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Palmer WC and Patel T: Are common factors
involved in the pathogenesis of primary liver cancers? A
meta-analysis of risk factors for intrahepatic cholangiocarcinoma.
J Hepatol. 57:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Blechacz B and Gores GJ:
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and
treatment. Hepatology. 48:308–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kim SJ, Lee JM, Han JK, Kim KH, Lee JY and
Choi BI: Peripheral mass-forming cholangiocarcinoma in cirrhotic
liver. AJR Am J Roentgenol. 189:1428–1434. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Quaia E, Angileri R, Arban F, Gennari AG
and Cova MA: Predictors of intrahepatic cholangiocarcinoma in
cirrhotic patients scanned by gadobenate dimeglumine-enhanced
magnetic resonance imaging: Diagnostic accuracy and confidence.
Clin Imaging. 39:1032–1038. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Iavarone M, Piscaglia F, Vavassori S,
Galassi M, Sangiovanni A, Venerandi L, Forzenigo LV, Golfieri R,
Bolondi L and Colombo M: Contrast enhanced CT-scan to diagnose
intrahepatic cholangiocarcinoma in patients with cirrhosis. J
Hepatol. 58:1188–1193. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Khan SA, Thomas HC, Davidson BR and
Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 366:1303–1314.
2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ciresa M, De Gaetano AM, Pompili M,
Saviano A, Infante A, Montagna M, Guerra A, Giuga M, Vellone M,
Ardito F, et al: Enhancement patterns of intrahepatic mass-forming
cholangiocarcinoma at multiphasic computed tomography and magnetic
resonance imaging and correlation with clinicopathologic features.
Eur Rev Med Pharmacol Sci. 19:2786–2797. 2015.PubMed/NCBI
|
14
|
Kang Y, Lee JM, Kim SH, Han JK and Choi
BI: Intrahepatic mass-forming cholangiocarcinoma: Enhancement
patterns on gadoxetic acid-enhanced MR Images. Radiology.
264:751–760. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kim R, Lee JM, Shin CI, Lee ES, Yoon JH,
Joo I, Kim SH, Hwang I, Han JK and Choi BI: Differentiation of
intrahepatic mass-forming cholangiocarcinoma from hepatocellular
carcinoma on gadoxetic acid-enhanced liver MR imaging. Eur Radiol.
26:1808–1817. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Maetani Y, Itoh K, Watanabe C, Shibata T,
Ametani F, Yamabe H and Konishi J: MR imaging of intrahepatic
cholangiocarcinoma with pathologic correlation. AJR Am J
Roentgenol. 176:1499–1507. 2001. View Article : Google Scholar : PubMed/NCBI
|
17
|
Chung YE, Kim MJ, Park YN, Choi JY, Pyo
JY, Kim YC, Cho HJ, Kim KA and Choi SY: Varying appearances of
cholangiocarcinoma: Radiologic-pathologic correlation.
Radiographics. 29:683–700. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Semelka RC, Martin DR, Balci C and Lance
T: Focal liver lesions: Comparison of dual-phase CT and
multisequence multiplanar MR imagingincluding dynamic gadolinium
enhancement. J Magn Reson Imaging. 13:397–401. 2001. View Article : Google Scholar : PubMed/NCBI
|
19
|
Tsunematsu S, Chuma M, Kamiyama T,
Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo
H, Kakisaka T, et al: Intratumoral artery on contrast-enhanced
computed tomography imaging: Differentiating intrahepatic
cholangiocarcinoma from poorly differentiated hepatocellular
carcinoma. Abdom Imaging. 40:1492–1499. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Mosconi S, Beretta GD, Labianca R, Zampino
MG, Gatta G and Heinemann V: Cholangiocarcinoma. Crit Rev Oncol
Hematol. 69:259–270. 2009. View Article : Google Scholar : PubMed/NCBI
|